Green Daniel M, Li Kendrick, Kaste Sue C, Ness Kirsten K, Krasin Matthew J, Xie Lu, Wilson Carmen L, Srivastava DeoKumar, Jay Dennis W, Davidoff Andrew M, Zahr Rima S, Taneja Siddhant, Shelton Kyla C, Lanctot Jennifer Q, Dixon Stephanie B, Ehrhardt Matthew J, Mulrooney Daniel A, Armstrong Gregory T, Robison Leslie L, Hudson Melissa M
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pediatr Blood Cancer. 2025 Mar;72(3):e31485. doi: 10.1002/pbc.31485. Epub 2024 Dec 17.
The relationships among treatment exposures, body composition, and estimated glomerular filtration rate (eGFR) in adult survivors of Wilms tumor have not been well studied.
We evaluated body composition with dual-energy x-ray absorptiometry (DXA) and eGFR with the updated Chronic Kidney Disease Epidemiology Collaboration equations (creatinine only-eGFR, cystatin C only-eGFR, creatinine and cystatin C-eGFR) without race in 134 adults previously treated for unilateral, non-syndromic Wilms tumor at St. Jude Children's Research Hospital between 1964 and 2004 with chemotherapy and with (hemiabdomen [HA] or whole abdomen [WA]) or without radiation therapy (RT). Z-scores for DXA variables were calculated using data from the National Health and Nutrition Examination Survey.
WART was associated with a lower relative total (p = 0.004) and trunk (p < 0.001) lean mass, eGFR (p = 0.008), eGFR (p < 0.001), and eGFR (p < 0.001), and higher values of cystatin C (p < 0.001). Linear regression demonstrated that relative total lean mass (p = 0.009) and relative trunk lean mass (p < 0.001) Z-scores, and eGFR (p = 0.013) were lower among those who received WART compared to No RT patients.
WART is associated with lower relative total and trunk lean mass Z-scores and eGFR, regardless of the equation used, and is lower in survivors treated with WART compared to unirradiated survivors of unilateral, non-syndromic WT. Assessments using other GFR measures may provide greater insight into the mechanism and magnitude of kidney function loss among WART-treated WT survivors.
肾母细胞瘤成年幸存者的治疗暴露、身体成分与估计肾小球滤过率(eGFR)之间的关系尚未得到充分研究。
我们采用双能X线吸收法(DXA)评估身体成分,并使用更新的慢性肾脏病流行病学协作方程(仅肌酐-eGFR、仅胱抑素C-eGFR、肌酐和胱抑素C-eGFR)在不考虑种族的情况下,对134名曾于1964年至2004年在圣裘德儿童研究医院接受单侧、非综合征性肾母细胞瘤治疗的成年人进行eGFR评估,这些患者接受了化疗,且接受(半腹部[HA]或全腹部[WA])或未接受放射治疗(RT)。使用来自美国国家健康和营养检查调查的数据计算DXA变量的Z分数。
肾母细胞瘤放疗与较低的相对总(p = 0.004)和躯干(p < 0.001)瘦体重、eGFR(p = 0.008)、eGFR(p < 0.001)以及eGFR(p < 0.001)相关,且胱抑素C值较高(p < 0.001)。线性回归表明,与未接受放疗的患者相比,接受肾母细胞瘤放疗的患者相对总瘦体重(p = 0.009)和相对躯干瘦体重(p < 0.001)Z分数以及eGFR(p = 0.013)较低。
无论使用何种方程,肾母细胞瘤放疗均与较低的相对总瘦体重和躯干瘦体重Z分数以及eGFR相关,且与单侧、非综合征性肾母细胞瘤未接受放疗的幸存者相比,接受肾母细胞瘤放疗的幸存者的上述指标更低。使用其他肾小球滤过率测量方法进行评估可能会更深入地了解接受肾母细胞瘤放疗的肾母细胞瘤幸存者肾功能丧失的机制和程度。